More of your ILD patients may be at risk for Progressive Fibrosis than you think1
Progressive fibrosis was defined as fibrosis detected by HRCT (reticular abnormality with traction bronchiectasis with or without honeycombing) that was progressive in terms of worsening of lung function (FVC and/or DLCO) and/or respiratory symptoms and/or chest images.
Percentage of patients with ILD who HAVE progressive fibrosis*
CTD-ILD, connective tissue disease-associated interstitial lung disease; DLco, diffusing capacity for carbon monoxide; FVC, forced vital capacity; HP, hypersensitivity pneumonitis; HRCT, high-resolution computed tomography; IIP, idiopathic interstitial pneumonia; IPF, idiopathic pulmonary fibrosis; PF-ILD, progressive fibrosing-interstitial lung disease; RA-ILD, rheumatoid arthritis-associated interstitial lung disease; SSc-ILD, systemic sclerosis-associated interstitial lung disease.
*According to an online survey of physicians.
Reference: 1. Wijsenbeek M et al. Poster presented at: American Thoracic Society International Conference; May 18-23, 2018; San Diego, CA.